Three‐Year Follow‐Up of the Phase II Trial for Resectable Non‐Small‐Cell Lung Cancer Treated With Perioperative Sintilimab and Neoadjuvant Anlotinib Plus Chemotherapy: TD‐NeoFOUR Trial. - Gao, Zhiyuan; Mao, Yajie; Sun, Yichen; Tong, Liping; Liu, Honggang; Wang, Tianhu; Shao, Changjian; Duan, Hongtao; Yan, Xiaolong (Thoracic Cancer, 2025)